Polypeptides-Based Nanocarriers in Tumor Therapy
Cancer remains a worldwide problem, and new treatment strategies are being actively developed. Peptides have the characteristics of good biocompatibility, strong targeting, functional diversity, modifiability, membrane permeable ability, and low immunogenicity, and they have been widely used to cons...
Saved in:
| Main Authors: | Juhua You, Yifei Guo, Zhengqi Dong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/16/9/1192 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delivery of Polypeptide Drugs Using Nanoparticles Made of Recombinant Spider Silks Derived From MaSp4 Protein
by: Peng Z, et al.
Published: (2025-03-01) -
Harnessing nature: plant-derived nanocarriers for targeted drug delivery in cancer therapy
by: Esther Ugo Alum, et al.
Published: (2025-08-01) -
Innovative nanocarriers: Synthetic and biomimetic strategies for enhanced drug delivery
by: Runzi Guo, et al.
Published: (2025-10-01) -
Targeted Hybrid Nanocarriers as Co-Delivery Systems for Enhanced Cancer Therapy
by: Joan Onyebuchi Erebor, et al.
Published: (2024-10-01) -
How Effective are Key Phytocompound Carrying Polysaccharide Nanocarriers as Anti-Breast Cancer Therapy? A Comprehensive Review of the Literature
by: Elsori D, et al.
Published: (2025-06-01)